Alzamend Neuro Inc.

Alzamend Neuro Inc. Committed to Treatments and Cures of Alzheimer’s Disease, Bipolar Disorder, Major Depressive Disorder

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. In most people with Alzheimer’s, symptoms first appear in their mid-60s. Alzheimer’s disease is the most common cause of dementia among older adults.

Find out more about our current clinical trial and overall pipeline at http://alzamend.com $ALZN
06/08/2026

Find out more about our current clinical trial and overall pipeline at http://alzamend.com $ALZN

Our most advanced product candidate AL001 is a patented ionic cocrystal technology delivering a therapeutic combination ...
06/05/2026

Our most advanced product candidate AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, proline and salicylate. Learn more about AL001 and our current Phase II clinical trial at http://alzamend.com $ALZN

Alzamend anticipates that AL001 may qualify for the 505(b)(2) NDA pathway to FDA approval based on its safety profile, a...
05/28/2026

Alzamend anticipates that AL001 may qualify for the 505(b)(2) NDA pathway to FDA approval based on its safety profile, as this pathway is available for new formulations of approved drugs. $ALZN

$ALZN
05/27/2026

$ALZN

For further information on our current AL001 clinical trial and pipeline, please go to https://alzamend.com $ALZ...
05/26/2026

For further information on our current AL001 clinical trial and pipeline, please go to https://alzamend.com $ALZN

Address

3480 Peachtree Road NE, 2nd Floor
Atlanta, GA
30326

Website

Alerts

Be the first to know and let us send you an email when Alzamend Neuro Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Alzamend Neuro Inc.:

Shortcuts

Share

Category